171 related articles for article (PubMed ID: 21259237)
1. Multivariate optimization of formulation variables influencing flurbiprofen proniosomes characteristics.
Zidan AS; Mokhtar M
J Pharm Sci; 2011 Jun; 100(6):2212-21. PubMed ID: 21259237
[TBL] [Abstract][Full Text] [Related]
2. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
Wen MM; Farid RM; Kassem AA
J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
[TBL] [Abstract][Full Text] [Related]
3. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes.
Mokhtar M; Sammour OA; Hammad MA; Megrab NA
Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of flurbiprofen microemulsion.
Ambade KW; Jadhav SL; Gambhire MN; Kurmi SD; Kadam VJ; Jadhav KR
Curr Drug Deliv; 2008 Jan; 5(1):32-41. PubMed ID: 18220549
[TBL] [Abstract][Full Text] [Related]
5. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
[TBL] [Abstract][Full Text] [Related]
7. Novel non-ionic surfactant proniosomes for transdermal delivery of lacidipine: optimization using 2(3) factorial design and in vivo evaluation in rabbits.
Soliman SM; Abdelmalak NS; El-Gazayerly ON; Abdelaziz N
Drug Deliv; 2016 Jun; 23(5):1608-22. PubMed ID: 26758033
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of proniosomes as a drug carrier for flurbiprofen.
Ibrahim MM; Sammour OA; Hammad MA; Megrab NA
AAPS PharmSciTech; 2008; 9(3):782-90. PubMed ID: 18587650
[TBL] [Abstract][Full Text] [Related]
9. Maximized mucoadhesion and skin permeation of anti-AIDS-loaded niosomal gels.
Zidan AS; Habib MJ
J Pharm Sci; 2014 Mar; 103(3):952-64. PubMed ID: 24464823
[TBL] [Abstract][Full Text] [Related]
10. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.
Aboelwafa AA; El-Setouhy DA; Elmeshad AN
AAPS PharmSciTech; 2010 Dec; 11(4):1591-602. PubMed ID: 21063815
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of skin permeation of flurbiprofen via its transdermal patches using isopulegol decanoate (ISO-C10) as an absorption enhancer: pharmacokinetic and pharmacodynamic evaluation.
Chen Y; Quan P; Liu X; Guo W; Song W; Cun D; Wang Z; Fang L
J Pharm Pharmacol; 2015 Sep; 67(9):1232-9. PubMed ID: 25994482
[TBL] [Abstract][Full Text] [Related]
13. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
14. Effect of olive oil on transdermal penetration of flurbiprofen from topical gel as enhancer.
Hussain A; Khan GM; Jan SU; Shah S; Shah K; Akhlaq M; Rahim N; Nawaz A; Wahab A
Pak J Pharm Sci; 2012 Apr; 25(2):365-9. PubMed ID: 22459463
[TBL] [Abstract][Full Text] [Related]
15. Proniosomes as a carrier system for transdermal delivery of tenoxicam.
Ammar HO; Ghorab M; El-Nahhas SA; Higazy IM
Int J Pharm; 2011 Feb; 405(1-2):142-52. PubMed ID: 21129461
[TBL] [Abstract][Full Text] [Related]
16. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
17. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
[TBL] [Abstract][Full Text] [Related]
18. The effect of critical process parameters of the high pressure homogenization technique on the critical quality attributes of flurbiprofen nanosuspensions.
Oktay AN; Ilbasmis-Tamer S; Celebi N
Pharm Dev Technol; 2019 Dec; 24(10):1278-1286. PubMed ID: 31535942
[TBL] [Abstract][Full Text] [Related]
19. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
[TBL] [Abstract][Full Text] [Related]
20. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.
El-Sayed MM; Hussein AK; Sarhan HA; Mansour HF
Drug Dev Ind Pharm; 2017 Jun; 43(6):902-910. PubMed ID: 27977311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]